Four years ago, after entering what is known as menopause, I began to suffer from asteatotic eczema caused by dryness every ...
A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus ...
Roivant's brepocitinib (Lisraya) succeeded in two non-infectious uveitis trials, with plans to file for approval in H1 2027.
Identify R&D opportunities through pipeline benchmarking, clinical-stage analysis, unmet needs, collaborations, licensing, mergers and acquisitions.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Atopic ...
The approval only covers a narrow group of rectal cancer patients, but for them it may rewrite what treatment looks like.
Asianet Newsable on MSN
AstraZeneca launches targeted lung cancer drug in US after FDA accelerated approval
AstraZeneca’s Zegfrovy demonstrated a 46% overall response rate in a trial supporting its accelerated FDA approval, as the ...
Hello, I'm Nurse komugi☺️🌾Have you ever had an experience like this after taking medicine?"I felt sleepy after taking the ...
Researchers combined self-reported experiences from thousands of patients with health and genetic data to investigate ...
GSK, the FTSE 100 drugmaker, said its immunotherapy Jemperli (dostarlimab) produced a complete response in 76% of patients ...
It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...
It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...
A 2026 narrative review finds that most myeloid-directed cancer programs show target activity without proving immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results